Description
Enzyme Immunoassay for the estimation of Cetuximab (ERBITUX) in serum and plasma.Key features:1. Developed using highly specific monoclonal anti-idiotypic antibodies in a sandwich assay format2. Validated as per international bioassay validation guidelines3. Recovery: 80-120%4. Precision CV less than 10%